Zi Shen Huo Luo Formula Enhances the Therapeutic Effects of Angiotensin-Converting Enzyme Inhibitors on Hypertensive Left Ventricular Hypertrophy by Interfering With Aldosterone Breakthrough and Affecting Caveolin-1/Mineralocorticoid Receptor Colocalization and Downstream Extracellular Signal-Regulated Kinase Signaling

Left ventricular hypertrophy (LVH) is an important characteristic of hypertensive heart disease. Renin-angiotensin system (RAS) blockers have been shown to be effective drugs for the reversal of LVH. Clinical and experimental studies have shown that Zi Shen Huo Luo Formula (ZSHLF) can improve the ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Xiaotong, Zhao, Yue, Wang, Shijun, Wang, Yuan, Chen, Qian, Zhao, Haijun, Wang, Hua, Tian, Sheng, Yu, Huayun, Wu, Zhichun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147343/
https://www.ncbi.nlm.nih.gov/pubmed/32317965
http://dx.doi.org/10.3389/fphar.2020.00383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147343/
https://www.ncbi.nlm.nih.gov/pubmed/32317965
http://dx.doi.org/10.3389/fphar.2020.00383

Ejemplares similares